Milademetan tosylate hydrate is the tosylate salt form of milademetan, an orally active small-molecule inhibitor of the MDM2-p53 interaction used in preclinical oncology research. Supplied as a research-use reagent, it is characterized by CAS 2095625-97-9, a molecular weight of 808.74 g/mol, and supporting documentation for laboratory use.
- Salt form (tosylate hydrate) for improved handling and stability.
- Orally active MDM2 inhibitor that facilitates p53 pathway reactivation.
- High purity suitable for analytical and preclinical studies (98.9%).
- Available in small pack sizes suitable for lab-scale experiments.
- Includes datasheet, certificate of analysis, and safety information for lab use.